Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

23.30
Delayed Data
As of Feb 24
 -0.45 / -1.89%
Today’s Change
17.92
Today|||52-Week Range
36.83
-33.05%
Year-to-Date

Today’s Trading

Previous close23.75
Today’s open23.65
Day’s range23.16 - 23.85
Volume513,878
Average volume (3 months)1,176,395
Market cap$800.1M
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-107.53%
Earnings growth (this year)+11.64%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+27.21%
P/E ratio54.2
Price/Sales2.25
Price/Book0.86

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc-0.46-2.21%
EDITEditas Medicine Inc-0.05-0.21%
CRSPCRISPR Therapeutics ...+0.26+1.47%
EPZMEpizyme Inc+0.45+3.85%
Data as of 4:00pm ET, 02/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$532.1M
Annual profit (last year)-$2.5M
Net profit margin-0.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs